News

Exosome Diagnostics announces it has entered an agreement with Merck KGaA. The collaboration will cover therapeutic development in oncology.

Considerable research into perovskites has proved the material's effectiveness at converting sunlight into electricity.

Using advanced fermentation technology, Manus Bio hopes to make manufacturing flavours, fragrances, and other products greener and more cost-effective, and create new products in the process.

A method has been developed for labelling fatty acids with bromine, and applied scanning X-ray fluorescence microscopy and mass spectrometry.

A new study shows how ribosome chaperones work, using X-ray crystallography to solve the atomic structure of the ribosomal protein bound to its chaperone.

Protagen AG has joined forces with the National Cancer Institute, to utilize Protagens SeroTag immune system profiling technology to identify new biomarkers.

Homeostatic scaling-down of synapses is important for memory consolidation. Profiled in the journal Science, Johns Hopkins researchers show that synaptic protein Homer1a is intimately involved in this process.

A new method has been developed that reliably hinders hazardous seawater fouling and is effective, affordable, and easy on the environment.

New company creates innovative drugs for novel targets using platform from the Scripps Research Institute, that radically expands druggability of the human proteome.

Millennium Health announced the publication of a new study that identifies hydrocodone and morphine as metabolites in oral fluid using Liquid Chromatography with Tandem Mass Spectrometry (LC-MS/MS) in patients prescribed codeine.